Heart failure trials in United Kingdom
95 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEndovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection Fraction
- Where
- Leeds, London
- Age
- 40 years and over
- People
- 50 worldwide
- Run by
- Axon Therapies, Inc.
See details and how to joinNCT07403058 - No phaseTaking peopleProduct Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Where
- Birmingham, Blackpool, Bristol, Leeds, Leicester, Liverpool, London, Manchester, Middlesbrough, Northampton, Nottingham, Sheffield, Southampton
- People
- 20,000 worldwide
- Run by
- Medtronic
See details and how to joinNCT00271180 - Phase 3Taking peopleStudy With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Where
- Basingstoke, Cottingham, Dudley, Dundonald, Glasgow, Harefield, Southampton, Swindon
- Age
- 18 years to 85 years
- People
- 1,800 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT06736574 · EU 2024-519219-32-00 - No phaseTaking peopleELEVATE-HFpEF Clinical Study
- Where
- Leeds, London, Manchester
- Age
- 40 years and over
- People
- 700 worldwide
- Run by
- Medtronic Cardiac Rhythm and Heart Failure
See details and how to joinNCT06678841 - Phase 2/3Taking peopleEfficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Where
- London, Newcastle upon Tyne
- Age
- 29 days to 17 years
- People
- 342 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05714085 · EU 2022-501238-52-00 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Airdrie, Ashington, Belfast, Bournemouth, Bridgend, Bristol, Chichester, Dundee, Exeter, Glasgow, Great Cambourne, High Wycombe, Inverness, Kilmarnock, Leicester, London, Manchester, Newcastle upon Tyne, Portadown, Craigavon, Sandbach, Stockton-on-Tees, Thetford, Wakefield, West Kirby
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - Phase 3Taking peopleA Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Where
- Barnet, Bristol, Exeter, Halifax, High Wycombe, London, Oldham, Sheffield, Truro, York
- Age
- 18 years and over
- People
- 6,712 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06424288 · EU 2023-509706-30-00 - Phase 3Taking peopleA Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Where
- Bristol, Clydebank, Exeter, Halifax, Harrow, London
- Age
- 18 years and over
- People
- 4,200 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06935370 · EU 2024-519525-38-00 - Phase 3Taking peopleA Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Belfast, Bristol, Glasgow, Leeds, Leicester, Liverpool, Newcastle upon Tyne
- Age
- Up to 18 years
- People
- 117 worldwide
- Run by
- Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00 - Phase 2Taking peopleA Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Where
- Belfast, Chichester, Dundee, High Wycombe, London, Norwich, Sheffield
- Age
- 18 years to 79 years
- People
- 620 worldwide
- Run by
- Pfizer
See details and how to joinNCT06991257 · EU 2024-518438-94-00 - Phase 3Taking peoplePhase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Where
- Aberdeen, Chesterfield, Dundee, Gatley, Glasgow, London, Norwich, Penzance, Redruth, Sandbach, Southampton, Swansea, Weston-super-Mare, Wolverhampton, Woodbridge, Yate
- Age
- 40 years and over
- People
- 11,300 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00 - Phase 3Taking peopleCLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Where
- Bellshill, Birmingham, Cardiff, Liverpool, London, Manchester
- Age
- 18 years and over
- People
- 1,280 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07207811 - No phaseTaking peopleArterial Stiffness and Endothelial Function in Heart Failure
- Where
- Coventry
- Age
- 18 years to 90 years
- People
- 50
- Run by
- Coventry University
See details and how to joinNCT07713719 - No phaseNot yet taking people in United KingdomRight Heart Injury Monitoring on ECMO
- Where
- Cambridge
- Age
- 18 years and over
- People
- 30
- Run by
- Papworth Hospital NHS Foundation Trust
See details and how to joinNCT07880730 - No phaseEnrolling by invitationGlobal Utilization And Registry Database for Improved heArt preservatioN
- Where
- Manchester
- People
- 4,000 worldwide
- Run by
- Paragonix Technologies
See details and how to joinNCT04141605 - Phase 3Taking peopleA Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Belfast, Bristol, Glasgow, Leeds, Leicester, Liverpool, Newcastle upon Tyne
- Age
- 6 months to 17 years
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00 - Phase 2Taking peopleDose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
- Where
- London
- Age
- 18 years to 80 years
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07830719 · EU 2026-525974-21-00 - Phase 3Taking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Airdrie, Barnet, Cambridge, Clydebank, Exeter, Harefield, Hastings, High Wycombe, Kent, Kings Lynn, Lincoln, London, Middlesbrough, Portsmouth, Sheffield, Sunderland, Wakefield
- Age
- 18 years to 130 years
- People
- 3,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - No phaseTaking peopleProspective Evaluation of AI-ECG for SHD Detection
- Where
- Bristol, London
- Age
- 18 years to 90 years
- People
- 590
- Run by
- Imperial College London
See details and how to joinNCT07057466 - No phaseTaking peopleA Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
- Where
- Multiple Locations
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Bayer
See details and how to joinNCT07235462 - Phase 2Taking peopleA Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Where
- Birmingham, High Wycombe, London, Middlesbrough, Southampton
- Age
- 40 years to 84 years
- People
- 200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06979362 · EU 2024-515796-35-00 - No phaseNot yet taking people in United KingdomEffectiveness of Pollution Monitoring in Clinical Exercise Rehabilitation
- Where
- Leicester
- Age
- 18 years and over
- People
- 80
- Run by
- University of Leicester
See details and how to joinNCT07500948 - No phaseNot yet taking people in United KingdomRemote Monitoring and Optimization of Heart Failure Therapy
- Where
- Southampton
- Age
- 18 years to 85 years
- People
- 800 worldwide
- Run by
- Zoll Medical Corporation
See details and how to joinNCT07622472 - No phaseEnrolling by invitationFIND HF Risk-guided Screening for Heart Failure - Pilot Study
- Where
- Leeds
- Age
- 40 years and over
- People
- 475
- Run by
- University of Leeds
See details and how to joinNCT07367841 - No phaseTaking peoplePatient Selection and Long-Term Outcomes of Pace & Ablate Strategy in Atrial Fibrillation
- Where
- Liverpool
- Age
- 18 years and over
- People
- 2,600 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT07852221